5 things to know about the experimental treatment Charlie Gard might receive

What is "nucleoside bypass therapy," the treatment proposed for Charlie Gard, and how well has it worked in other patients? Here's what to know.

On Monday, Dr. Michio Hirano, a neurologist at Columbia University, will evaluate 11-month old Charlie Gard, the British boy who is on life support because of a rare, lethal disease called mitochondrial depletion syndrome.

Charlie is at the center of a concerning whether his parents can take him abroad to receive experimental treatment. Doctors at the hospital treating Charlie have said that every medical treatment option has already been explored, and

Estás leyendo una vista previa, regístrate para leer más.

Más de STAT

STAT1 min. leídos
STAT+: Pharmalittle: Hospitals Grapple With Extra Dose Of Pfizer Vaccine; FDA Panel Meets To Review Moderna Vaccine
With the Covid-19 vaccine in short supply, hospital pharmacists found themselves throwing away one in every six doses of the first vaccines distributed this week in the U.S.
STAT1 min. leídosMedical
STAT+: Pharmalittle: U.S. Considers Giving Half-doses Of Moderna Vaccine; Americans May Not Get AstraZeneca Shot Until April
The U.S. government is considering giving some people half the dose of the Moderna Covid-19 vaccine in order to speed vaccinations.
STAT1 min. leídosMedical
STAT+: Pharmalittle: Feds Sue Walmart Over Opioid Prescriptions; U.S. Buys More Pfizer Vaccine Doses
According to a 160-page civil complaint, Walmart knew its system for detecting suspicious prescriptions was faulty but did little to address the matter as its network of pharmacies filled millions…